About Rapid Genomics
Rapid Genomics is a Healthcare company based in Gainesville (United States) founded in 2011, and was acquired by LGC in April 2022. DNA sequencing services are provided for crop and livestock improvement. Rapid Genomics has raised $300 thousand across 1 funding round from investors including LGC. Rapid Genomics offers products and services including KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits. Its focus areas include Life Sciences, Genomics, Genomics Services and Sequencing. Its legal entity is Rapid Genomics LLC. Its competitors include Omniome, Rejuvenate Bio and Singular Genomics; 2 of its 3 listed competitors have raised funding.
Company details
Rapid Genomics was founded in 2011 in Gainesville, United States, and operates in the genomics sector focused on agriculture. DNA sequencing services are offered to enhance crops and livestock, utilizing capture-sequencing technology for custom targeted applications. Additional services include RNA sequencing, whole genome sequencing, ultraconserved elements analysis, next-generation sequencing, and bioinformatics support. Operations are centered on providing these tools to research and development efforts in the field.
- Headquarters Gainesville, United States
- Stage Acquired
- SectorsHealthcare
- Website rapid-genomics.com
- Social LinkedIn X Facebook
- Acquired by LGC (Apr 2022)
- Legal Name Rapid Genomics Llc
Products & Services of Rapid Genomics
Rapid Genomics offers a comprehensive portfolio of products and services, including KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits.
Reagents for qPCR-based genotyping in agriculture.
Custom oligonucleotides for DNA and RNA applications.
Devices for high-throughput PCR and genotyping.
Kits for amplicon-based targeted sequencing workflows.
Funding Insights of Rapid Genomics
Rapid Genomics has successfully raised a total of $300K through 1 strategic funding round. The most recent funding activity was a Seed round of $300 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $300,000
- Total Rounds 1
- Last Round Seed — $300,000
- First Round $300,000
(Oct 2015)
All 1 funding rounds of Rapid Genomics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2015 | $300,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Rapid Genomics
Rapid Genomics has secured backing from 1 investor. Prominent investors backing the company include LGC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Molecular biology reagents and services are supplied to biotech industries. | 1842 | lgcgroup.com | Teddington, United Kingdom |
Investor details for Rapid Genomics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Rapid Genomics
3 dated milestones of Rapid Genomics across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Rapid Genomics is founded.
- Funding First funding round of $300K.
- Exit Acquired by LGC.
Competitors of Rapid Genomics
Rapid Genomics has 3 listed competitors in our database, 2 of them funded. They include Omniome, Rejuvenate Bio and Singular Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| singulargenomics.com | 2016 | San Diego, United States | 169 | Next-generation gene sequencing and multi-omics technologies are provided. |
Detailed competitors of Rapid Genomics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Rapid Genomics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rapid Genomics
Complete news archive for Rapid Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rapid Genomics
Rapid Genomics was founded in 2011 and raised its 1st funding round 4 years after it was founded.
Rapid Genomics is headquartered in Gainesville, United States.
Rapid Genomics is a funded company, having raised a total of $300K across 1 funding round to date. The company's 1st funding round was a Seed of $300K, raised on Oct 2015.
Rapid Genomics was founded in 2011 in Gainesville, United States, and operates in the genomics sector focused on agriculture. DNA sequencing services are offered to enhance crops and livestock, utilizing capture-sequencing technology for custom targeted applications. Additional services include RNA sequencing, whole genome sequencing, ultraconserved elements analysis, next-generation sequencing, and bioinformatics support. Operations are centered on providing these tools to research and development efforts in the field.
Rapid Genomics's top competitors include Singular Genomics, Omniome and Rejuvenate Bio.
Rapid Genomics offers KASP Genotyping Reagents, Oligos and Primers, PCR Instruments, and NGS Kits.
Rapid Genomics has 1 investor. Key investors include LGC.
Rapid Genomics operates through Rapid Genomics Llc.
Yes. Rapid Genomics was acquired by LGC in April 2022.